Literature DB >> 15318121

On sensitivity, specificity, and the influence of various parameters on ethyl glucuronide levels in urine--results from the WHO/ISBRA study.

Friedrich Martin Wurst1, Gerhard A Wiesbeck, Jorg W Metzger, Wolfgang Weinmann.   

Abstract

BACKGROUND: Ethyl glucuronide (EtG), a direct ethanol metabolite, seems to meet the need for a sensitive and specific marker for monitoring recent alcohol consumption in different settings. Our aim was to study sensitivity, specificity, and the influence of various parameters on EtG levels in urine. PATIENTS AND METHODS: Urine samples for a total of 453 patients (373 male, 80 female) were statistically analyzed. The mean age was 37.1 years (median 36, SD 12.59), body mass index was 24.7, total ethanol consumed last month was 1817.66 g (each median), and 80 patients reported cannabis use within the last 30 days. Determination of EtG was performed with a liquid chromatography-tandem mass spectrometry method with deuterium-labeled EtG as internal standard.
RESULTS: For EtG in urine, a good correlation was found with other state markers and days of sobriety. In a regression analysis, age, gender, marijuana use, kidney disease, and total grams of ethanol consumed last month were the variables that significantly influenced EtG levels in contrast to race, smoking, body mass index, cirrhosis of liver, age began drinking regularly, packs of cigarettes smoked last month, and total body water. Furthermore, in a receiver operating characteristic curve analysis to distinguish between nondrinkers and individuals sober > 4 days versus individuals drinking in the recent 4 days, area under the curve was 0.834. At a cutoff of 0.145 mg/liter, sensitivity was 83.5% and specificity 68.3%. A receiver operating characteristic curve was calculated for lifetime alcohol abuse or dependence against those who had never been abusers or dependent. In this case, subjects were either never dependent or lifetime dependent, but those currently dependent were excluded. The resulting area under the curve was 0.694. At a cutoff of 0.145 mg/liter, sensitivity was 73.8% and specificity 60.3%. For those with a self-reported sobriety of less than 24 hr, the area under the curve was 0.899, sensitivity was 90.8%, and specificity was 76.5% at a cutoff of 0.435 mg/liter when we calculated nondrinkers and light drinkers against heavy drinkers and drinkers needing treatment. Cannabis-using patients showed significant differences with regard to almost all state markers when compared with nonconsuming subjects.
CONCLUSIONS: Age, gender, marijuana use, kidney disease, and total grams of ethanol consumed last month should be taken into consideration when interpreting results of EtG in urine. Sensitivity and specificity seem promising. Cannabis use can be regarded as an indicator for other serious mental problems in alcohol-using subjects. Copyright 2004 Research Society on Alcoholism

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15318121     DOI: 10.1097/01.alc.0000134230.21414.11

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  22 in total

1.  Clinical (nonforensic) application of ethyl glucuronide measurement: are we ready?

Authors:  Peter Jatlow; Stephanie S O'Malley
Journal:  Alcohol Clin Exp Res       Date:  2010-04-05       Impact factor: 3.455

2.  Evaluation of biomarkers assessing regular alcohol consumption in an occupational setting.

Authors:  Sonja Kilo; Birgit Hofmann; Elisabeth Eckert; Thomas Göen; Hans Drexler
Journal:  Int Arch Occup Environ Health       Date:  2016-07-09       Impact factor: 3.015

Review 3.  Biomarkers for detection of alcohol consumption in liver transplantation.

Authors:  Katharina Staufer; Michel Yegles
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

4.  Novel Objective Biomarkers of Alcohol Use: Potential Diagnostic and Treatment Management Tools in Dual Diagnosis Care.

Authors:  Raj K Kalapatapu; R Chambers
Journal:  J Dual Diagn       Date:  2009-01-01

5.  Determining ethyl glucuronide cutoffs when detecting self-reported alcohol use in addiction treatment patients.

Authors:  Jessica M Lowe; Michael G McDonell; Emily Leickly; Frank A Angelo; Roger Vilardaga; Sterling McPherson; Debra Srebnik; John Roll; Richard K Ries
Journal:  Alcohol Clin Exp Res       Date:  2015-04-10       Impact factor: 3.455

Review 6.  [What ethanol metabolites as biological markers tell us about alcohol use].

Authors:  Friedrich Martin Wurst; Natasha Thon; Wolfgang Weinmann; Michel Yegles; Ulrich Preuss
Journal:  Wien Med Wochenschr       Date:  2013-12-10

Review 7.  Liver Transplantation for Alcohol-Related Liver Disease.

Authors:  Narendra S Choudhary; Naveen Kumar; Sanjiv Saigal; Rahul Rai; Neeraj Saraf; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2016-02-27

8.  Commentary on: ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials.

Authors:  Raymond F Anton
Journal:  Alcohol Clin Exp Res       Date:  2014-06-24       Impact factor: 3.455

9.  A novel and an effective analytical approach for the LC-MS determination of ethyl glucuronide and ethyl sulfate in urine.

Authors:  Donata Favretto; Alessandro Nalesso; Giampietro Frison; Guido Viel; Pietro Traldi; Santo Davide Ferrara
Journal:  Int J Legal Med       Date:  2009-10-27       Impact factor: 2.686

10.  Kinetics in serum and urinary excretion of ethyl sulfate and ethyl glucuronide after medium dose ethanol intake.

Authors:  Claudia C Halter; Sebastian Dresen; Volker Auwaerter; Friedrich M Wurst; Wolfgang Weinmann
Journal:  Int J Legal Med       Date:  2007-06-09       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.